Osteogenex Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Osteogenex General Information

Description

Developer of a small molecule designed to increase bone density. The company offers a therapeutic approach with technologies to efficiently bring product candidates into clinical development and develop small-molecule therapeutics, enabling healthcare professionals to improve the probability of creating drugs that will improve the lives of patients.

Contact Information

Website
www.osteogenex.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • 11235 Mastin
  • Suite 102
  • Overland Park, KS 66210
  • United States
+1 (913)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 11235 Mastin
  • Suite 102
  • Overland Park, KS 66210
  • United States
+1 (913)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osteogenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 15-Jul-2023 Completed Out of Business
6. Grant 22-May-2013 Completed Generating Revenue
5. Angel (individual) 23-Jun-2011 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2010 Completed Generating Revenue
3. Grant 01-Jan-2008 Completed Generating Revenue
2. Grant 01-Jan-2006 $134K Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view Osteogenex’s complete valuation and funding history, request access »

Osteogenex Patents

  • 40

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Osteogenex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140023653-A1 Boldine derivatives for promoting bone growth Inactive 16-Jul-2012
US-20100249171-A1 Ellipticine compounds for treating obesity Active 17-Mar-2009
US-8513274-B2 Ellipticine compounds for treating obesity Inactive 17-Mar-2009
WO-2010107704-A2 Ellipticine compounds for treating obesity Inactive 17-Mar-2009
WO-2010107704-A3 Ellipticine compounds for treating obesity Inactive 17-Mar-2009 A61K31/475
To view Osteogenex’s complete patent history, request access »

Ready to get started?

Request a free trial

Osteogenex FAQs

  • When was Osteogenex founded?

    Osteogenex was founded in 2005.

  • Where is Osteogenex headquartered?

    Osteogenex is headquartered in Overland Park, KS.

  • What industry is Osteogenex in?

    Osteogenex’s primary industry is Drug Discovery.

  • Is Osteogenex a private or public company?

    Osteogenex is a Private company.

  • What is Osteogenex’s current revenue?

    The current revenue for Osteogenex is .

  • How much funding has Osteogenex raised over time?

    Osteogenex has raised $1.4M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process